<DOC>
	<DOCNO>NCT01730846</DOCNO>
	<brief_summary>The purpose study examine whether doxazosin attenuate ability stress precipitate smoking lapse behavior treatment seek daily smoker . Participants participate smoking cessation attempt laboratory session .</brief_summary>
	<brief_title>Does Doxazosin Attenuate Stress-induced Smoking Improve Clinical Outcomes ?</brief_title>
	<detailed_description />
	<mesh_term>Doxazosin</mesh_term>
	<criteria>Ages 1860 Able read write English Smoker Motivated Quit Smoking Any significant current medical condition would contraindicate smoking Current Diagnostic Statistical Manual Mental Disorders ( DSMIV ) abuse dependence substance , nicotine dependence alcohol abuse Positive test result intake appointment urine drug screen illicit drug Past 30 day use psychoactive drug include anxiolytic antidepressant Women pregnant nursing Suicidal , homicidal evidence current severe mental illness schizophrenia , bipolar disorder major depression , anxiety disorder Participants donate blood within past 6 week Individuals currently take medication prescribe smoke cessation Specific exclusions administration doxazosin alpha blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>smoke lapse behavior</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>doxazosin</keyword>
	<keyword>medication effect smoke lapse behavior</keyword>
	<keyword>medication effect smoking cessation</keyword>
	<keyword>stress</keyword>
</DOC>